Detalhe da pesquisa
1.
Evaluating the Necessity for Routine Sentinel Lymph Node Biopsy in Postmenopausal Patients Being Treated for Clinically Node Negative Breast Cancer the Era of RxPONDER.
Clin Breast Cancer
; 23(5): 500-507, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37076364
2.
A Novel Surrogate Nomogram Capable of Predicting OncotypeDX Recurrence Score©.
J Pers Med
; 12(7)2022 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35887614
3.
Comparison of the Nottingham Prognostic Index and OncotypeDX© recurrence score in predicting outcome in estrogen receptor positive breast cancer.
Breast
; 66: 227-235, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36335747
4.
Breast cancer recurrence: factors impacting occurrence and survival.
Ir J Med Sci
; 191(6): 2501-2510, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35076871
5.
Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer - A retrospective cohort study.
Breast
; 59: 67-75, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34171619